QDEL SEC Filings: 8-K, 10-Q, S-3 & 424B – QuidelOrtho

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 5, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 18, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2025

News

TYPE

HEADLINE

FILED AT

8-K

QuidelOrtho Reports Third Quarter 2026 Financial Results and Announces Cost Transformation Program

Nov 3, 2026

8-K

QuidelOrtho Enters into Amendment No. 1 to Credit Agreement Resetting Financial Covenants

Sep 23, 2026

8-K

QuidelOrtho Reports Second Quarter 2026 Financial Results and Updates Full-Year Guidance

Aug 6, 2026

8-K

QuidelOrtho Appoints Micah Young as Chief Financial Officer

Jun 23, 2026

8-K

QuidelOrtho Corporation Announces Results of 2026 Annual Meeting of Stockholders

Jun 16, 2026

8-K

QuidelOrtho Reports First Quarter 2026 Financial Results and Updates Full-Year Guidance

May 5, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

UPDATED | OFFERING | Shares amount: 8,260,183 | Share price: $35.60 | Offering amount: $294,062,514.80

Nov 20, 2024

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Apr 11, 2022

Registrations

TYPE

HEADLINE

FILED AT

S-8

QuidelOrtho Corporation Establishes 2026 Inducement Plan

Jul 13, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 27, 2025

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Nov 19, 2024

S-3ASR

SHARE RESALE REGISTRATION | Shares amount: 8,260,183 | Share price: $37.39

Nov 19, 2024

S-8 POS

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Aug 18, 2022

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 1, 2022

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 27, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 27, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 8, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 8, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 2, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 2, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Siegrist Jonathan Philip (Reporting)

Oct 19, 2026

SCHEDULE 13G/A

FMR LLC (Filed by)

Oct 7, 2026

Bowman Ronald Lee (Reporting)

Sep 17, 2026

Hanson Bryan Michael (Reporting)

Aug 18, 2026

SCHEDULE 13G/A

Newtyn Management, LLC (Filed by)

Aug 14, 2026

SCHEDULE 13G/A

T. Rowe Price Investment Management, Inc. (Filed by)

Aug 14, 2026

Other

TYPE

HEADLINE

FILED AT

Form SD - Specialized disclosure report

May 11, 2026

Form SD - Specialized disclosure report

May 22, 2025

Form SD - Specialized disclosure report

May 30, 2024

Form SD - Specialized disclosure report

May 31, 2023

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 12, 2022

CORRESP

Form CORRESP - Correspondence

Apr 8, 2022

QuidelOrtho Corporation QDEL · SEC Filings